SEC Form D · Amendment · filed September 15, 2015
PROTEOSTASIS THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Nadia J. Ustariz · CAMBRIDGE, MAExecHenry J. Skinner · CAMBRIDGE, MADirectorBernard J. Davitian · CAMBRIDGE, MADirectorStephen J. Knight · CAMBRIDGE, MADirectorChristopher J. Mirabelli · CAMBRIDGE, MADirectorJeffery J. Kelly · CAMBRIDGE, MADirectorMeenu J. Chhabra · CAMBRIDGE, MAExec · DirectorJanet J. Smart · CAMBRIDGE, MAExecM. J. Barrett · CAMBRIDGE, MADirectorChristopher J. Walsh · CAMBRIDGE, MADirectorConor J. Walshe · CAMBRIDGE, MADirectorThomas Arnold · Wilmington, DEDirectorPeter Pau · Menlo Park, CADirectorJames H. Richardson · Pasadena, CADirectorJeffrey D. Burningham · Provo, UTDirectorSameet Mehta · San Mateo, CADirectorJeffrey C. Danley · Provo, UTExecJames D. Dunn · Provo, UTDirectorThomas J. Andrews · Pasadena, CADirectorPeter M. Moglia · Pasadena, CAExec · DirectorDean A. Shigenaga · Pasadena, CADirectorJoel S. Marcus · Pasadena, CAExecDaniel J. Ryan · Pasadena, CAExec · DirectorRichard B. Jennings · Pasadena, CADirectorRichard H. Klein · Pasadena, CAExec · DirectorYC Continuity Management I, LLC · Mountain View, CADirectorLeif Abraham · New York, NYDirectorMartin Strutz · New York, NYExecDavid L. Flynn · Draper, UTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗